Engineered sEVs encapsulated in GelMA facilitated diabetic wound healing by promoting angiogenesis via targeting thrombospondin-1

Abstract

Background: Chronic nonhealing wounds are major complications in diabetic patients, with impaired angiogenesis playing a critical role in the delayed healing process. Current treatments for diabetic wounds are inadequate. The dysregulation of endothelial cell genes, particularly thrombospondin-1 (TSP-1), impairs neovascularization and delays wound repair. In recent years, hydrogel-based wound dressings have gained widespread application in biomedicine. The study introduced a new therapeutic approach, embedding miR-221-3p-loaded small extracellular vesicles (miR-221OE-sEVs) within gelatin methacryloyl (GelMA) hydrogels to reduce TSP-1 levels and improve healing in diabetic wounds. Methods: First, we observed upregulated TSP-1 expression in human umbilical vein endothelial cells (HUVECs) when cultured in a high-glucose (HG) environment. We employed small interfering RNA (siRNA) and miR-221-3p to suppress TSP-1 expression and then evaluate the functional effects on HUVECs. Subsequently, miR-221-3p was encapsulated in sEVs via lentiviral transfection. The effects of miR-221OE-sEVs on HUVECs under HG conditions were evaluated. Finally, miR-221OE-sEVs were incorporated into a GelMA hydrogel (G-miR-221OE-sEVs) and applied to a diabetic murine wound model to evaluate their effects on wound closure and angiogenesis. Results: Under HG conditions, the use of siTSP-1 to silence TSP-1 enhanced the proliferation, migration, and tube formation capabilities of HUVECs. Similarly, miR-221-3p treatment exerted proregenerative effects via the targeting of TSP-1. We successfully generated miR-221OE-sEVs that exhibited a 28-fold increase in miR-221-3p expression, which significantly enhanced HUVEC functionality under HG conditions. Encapsulation within the GelMA hydrogel enabled G-miR-221OE-sEVs to significantly accelerate diabetic wound healing via increased angiogenesis. Conclusions: This study demonstrated the successful fabrication of a novel bioactive wound dressing (G-miR-221OE-sEVs), which promotes diabetic wound healing by promoting angiogenesis through the regulation of TSP-1. This approach offers a potential therapeutic option for enhancing the management of diabetic wounds.

Keywords

Thrombospondin-1 / Angiogenesis / miR-221-3p / Diabetic wounds / Small extracellular vesicles

References

[1] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14: 88-98. https://doi.org/10.1038/nrendo.2017.151.

[2] Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119. https://doi.org/10.1016/j.diabres.2021.109119.

[3] Okonkwo UA, DiPietro LA. Diabetes and wound angiogenesis. Int J Mol Sci 2017; 18: 1419. https://doi.org/10.3390/ijms18071419.

[4] Falanga V.Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-43. https://doi.org/10.1016/s0140-6736(05)67700-8.

[5] Baltzis D, Eleftheriadou I, Veves A.Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther 2014; 31: 817-36. https://doi.org/10.1007/s12325-014-0140-x.

[6] Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 2014; 6: 265sr6. https://doi.org/10.1126/scitranslmed.3009337.

[7] Gutierrez LS, Gutierrez J. Thrombospondin 1 in metabolic diseases. Front Endocrinol (Lausanne) 2021; 12: 638536. https://doi.org/10.3389/fendo.2021.638536.

[8] Bornstein P.Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 2009; 3: 189-200. https://doi.org/10.1007/s12079-009-0060-8.

[9] Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001; 107: 929-34. https://doi.org/10.1172/jci12749.

[10] Lan CC, Huang SM, Wu CS, Wu CH, Chen GS. High-glucose environment increased thrombospondin-1 expression in keratinocytes via DNA hypomethylation. Transl Res 2016; 169: 91-101.e3. https://doi.org/10.1016/j.trsl.2015.11.002.

[11] Han X, Tao Y, Deng Y, Yu J, Sun Y, Jiang G. Metformin accelerates wound healing in type 2 diabetic db/db mice. Mol Med Rep 2017; 16: 8691-8. https://doi.org/10.3892/mmr.2017.7707.

[12] Zhu ML, Fan JX, Guo YQ, Guo LJ, Que HD, Cui BY, et al. Protective effect of alizarin on vascular endothelial dysfunction via inhibiting the type 2 diabetes-induced synthesis of THBS1 and activating the AMPK signaling pathway. Phytomedicine 2024; 128: 155557. https://doi.org/10.1016/j.phymed.2024.155557.

[13] Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014; 15: 509-24. https://doi.org/10.1038/nrm3838.

[14] Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610. https://doi.org/10.1038/nrg2843.

[15] Hussen BM, Rasul MF, Abdullah SR, Hidayat HJ, Faraj GSH, Ali FA, et al. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges. Mil Med Res 2023; 10: 32. https://doi.org/10.1186/s40779-023-00468-6.

[16] Wang P, Zhou Y, Richards AM. Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry. Theranostics 2021; 11: 8771-96. https://doi.org/10.7150/thno.62642.

[17] Su J, Wei Q, Ma K, Wang Y, Hu W, Meng H, et al. P-MSC-derived extracellular vesicles facilitate diabetic wound healing via miR-145-5p/CDKN1A-mediated functional improvements of high glucose-induced senescent fibroblasts. Burns Trauma 2023; 11: tkad010. https://doi.org/10.1093/burnst/tkad010.

[18] Liu Y, Li Q, Hosen MR, Zietzer A, Flender A, Levermann P, et al. Atherosclerotic conditions promote the packaging of functional MicroRNA-92a-3p into endothelial microvesicles. Circ Res 2019; 124: 575-87. https://doi.org/10.1161/circresaha.118.314010.

[19] Wei Q, Su J, Meng S, Wang Y, Ma K, Li B, et al. MiR-17-5p-engineered sEVs encapsulated in gel MA hydrogel facilitated diabetic wound healing by targeting PTEN and p21. Adv Sci (Weinh) 2024; 11: e2307761. https://doi.org/10.1002/advs.202307761.

[20] Kochhar P, Vukku M, Rajashekhar R, Mukhopadhyay A. microRNA signatures associated with fetal growth restriction: a systematic review. Eur J Clin Nutr 2022; 76: 1088-102. https://doi.org/10.1038/s41430-021-01041-x.

[21] Jin ZQ. MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis. Pharmacol Res 2021; 174: 105941. https://doi.org/10.1016/j.phrs.2021.105941.

[22] Proia P, Rossi C, Alioto A, Amato A, Polizzotto C, Pagliaro A, et al. MiRNAs expression modulates osteogenesis in response to exercise and nutrition. Genes (Basel) 2023; 14: 1667. https://doi.org/10.3390/genes14091667.

[23] Ruiz-Pozo VA, Cadena-Ullauri S, Guevara-Ramírez P, Paz-Cruz E, Tamayo-Trujillo R, Zambrano AK. Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer. Front Med (Lausanne) 2023; 10: 1139362. https://doi.org/10.3389/fmed.2023.1139362.

[24] Hu K, Liu X, Chang H, Zhang Y, Zhou H, Liu L, et al. MicroRNA-221-3p targets THBS1 to promote wound healing in diabetes. Diabetes Metab Syndr Obes 2023; 16: 2765-77. https://doi.org/10.2147/DMSO.S424847.

[25] Chen T, Song P, He M, Rui S, Duan X, Ma Y, et al. Sphingosine-1-phosphate derived from PRP-exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signalling pathway. Burns Trauma 2023; 11: tkad003. https://doi.org/10.1093/burnst/tkad003.

[26] Zhang Y, Wu D, Zhou C, Bai M, Wan Y, Zheng Q, et al. Engineered extracellular vesicles for tissue repair and regeneration. Burns Trauma 2024; 12: tkae062. https://doi.org/10.1093/burnst/tkae062.

[27] Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem 2019; 88: 487-514. https://doi.org/10.1146/annurev-biochem-013118-111902.

[28] Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science 2020; 367: eaau6977. https://doi.org/10.1126/science.aau6977.

[29] Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, et al. Exosome processing and characterization approaches for research and technology development. Adv Sci (Weinh) 2022; 9: e2103222. https://doi.org/10.1002/advs.202103222.

[30] Qin X, He J, Wang X, Wang J, Yang R, Chen X. The functions and clinical application potential of exosomes derived from mesenchymal stem cells on wound repair: a review of recent research advances. Front Immunol 2023; 14: 1256687. https://doi.org/10.3389/fimmu.2023.1256687.

[31] Huang Q, Chu Z, Wang Z, Li Q, Meng S, Lu Y, et al. circCDK13-loaded small extracellular vesicles accelerate healing in preclinical diabetic wound models. Nat Commun 2024; 15: 3904. https://doi.org/10.1038/s41467-024-48284-3.

[32] Yang Q, Li J, Meng H, Wang Y, Hu L, Su W, et al. Coaxial electrospun nanofibrous membranes as dual-functional biomimetic tendon sheath for tendon repair and anti-peritendinous adhesion. Adv Healthc Mater 2025; 14: e2402074. https://doi.org/10.1002/adhm.202402074.

[33] He C, Yin M, Zhou H, Qin J, Wu S, Liu H, et al. Magnetic nanoactuator-protein Fiber coated hydrogel dressing for well-balanced skin wound healing and tissue regeneration. ACS Nano 2025; 19: 1713-31. https://doi.org/10.1021/acsnano.4c15647.

[34] Ahn W, Han J, Kim N, Hwang YH, Kim W, Lee Y, et al. Hierarchical protein nano-crystalline hydrogel with extracellular vesicles for ectopic lymphoid structure formation. Biomaterials 2025; 318: 123166. https://doi.org/10.1016/j.biomaterials.2025.123166.

[35] Meng J, Lu J, Jiang C, Deng L, Xiao M, Feng J, et al. Collagen hydrogel-driven pyroptosis suppression and combined microfracture technique delay osteoarthritis progression. Biomaterials 2025; 314: 122817. https://doi.org/10.1016/j.biomaterials.2024.122817.

[36] Peng X, Wang T, Dai B, Zhu Y, Ji M, Yang P, et al. Gene therapy for inflammatory Cascade in intrauterine injury with engineered extracellular vesicles hybrid snail mucus-enhanced adhesive hydrogels. Adv Sci (Weinh) 2025; 12:e2410769. https://doi.org/10.1002/advs.202410769.

[37] Ren C, Chen W, Liao Y, Huang Y, Yu C, Chen T, et al. Reinforcing Gelatin hydrogels via In situ phase separation and enhanced interphase bonding for advanced 3D fabrication. Adv Mater 2025; 37: e2416432. https://doi.org/10.1002/adma.202416432.

[38] Alvarez MM, Cantoral-Sánchez A, Trujillo-de Santiago G. Chaotic (bio)printing in the context of drug delivery systems. Adv Drug Deliv Rev 2025; 216: 115475. https://doi.org/10.1016/j.addr.2024.115475.

[39] Yoon DS, Lee Y, Ryu HA, Jang Y, Lee KM, Choi Y, et al. Cell recruiting chemokine-loaded sprayable gelatin hydrogel dressings for diabetic wound healing. Acta Biomater 2016; 38: 59-68. https://doi.org/10.1016/j.actbio.2016.04.030.

[40] Chang TT, Li YZ, Mo HW, Chen C, Lin LY, Chang CC, et al. Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus. Sci Transl Med 2024; 16: eadn1507. https://doi.org/10.1126/scitranslmed.adn1507.

[41] Meng S, Wei Q, Chen S, Liu X, Cui S, Huang Q, et al. MiR-141-3p-functionalized exosomes loaded in dissolvable microneedle arrays for hypertrophic scar treatment. Small 2024; 20: e2305374. https://doi.org/10.1002/smll.202305374.

[42] Jia G, Han Y, An Y, Ding Y, He C, Wang X, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials 2018; 178: 302-16. https://doi.org/10.1016/j.biomaterials.2018.06.029.

[43] Wang Y, Cao Z, Wei Q, Ma K, Hu W, Huang Q, et al. VH298-loaded extracellular vesicles released from gelatin methacryloyl hydrogel facilitate diabetic wound healing by HIF-1alpha-mediated enhancement of angiogenesis. Acta Biomater 2022; 147: 342-55. https://doi.org/10.1016/j.actbio.2022.05.018.

[44] Zhang W, Bao B, Jiang F, Zhang Y, Zhou R, Lu Y, et al. Promoting oral mucosal wound healing with a hydrogel adhesive based on a phototriggered S-nitrosylation coupling reaction. Adv Mater 2021; 33:e2105667. https://doi.org/10.1002/adma.202105667.

[45] Martin KE, Hunckler MD, Chee E, Caplin JD, Barber GF, Kalelkar PP, et al. Hydrolytic hydrogels tune mesenchymal stem cell persistence and immunomodulation for enhanced diabetic cutaneous wound healing. Biomaterials 2023; 301: 122256. https://doi.org/10.1016/j.biomaterials.2023.122256.

[46] Peng Y, He D, Ge X, Lu Y, Chai Y, Zhang Y, et al. Construction of heparin-based hydrogel incorporated with Cu5.4O ultrasmall nanozymes for wound healing and inflammation inhibition. Bioact Mater 2021; 6: 3109-24. https://doi.org/10.1016/j.bioactmat.2021.02.006.

[47] Cui S, Liu X, Liu Y, Hu W, Ma K, Huang Q, et al. Autophagosomes defeat ferroptosis by decreasing generation and increasing discharge of free Fe(2+) in skin repair cells to accelerate diabetic wound healing. Adv Sci (Weinh) 2023; 10: e2300414. https://doi.org/10.1002/advs.202300414.

[48] Lu A, Miao M, Schoeb TR, Agarwal A, Murphy-Ullrich JE. Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy. Am J Pathol 2011; 178: 2573-86. https://doi.org/10.1016/j.ajpath.2011.02.039.

[49] Peng C, Yang LJ, Zhang C, Jiang Y, Shang LW, He JB, et al. Low-dose nifedipine rescues impaired endothelial progenitor cell-mediated angiogenesis in diabetic mice. Acta Pharmacol Sin 2023; 44: 44-57. https://doi.org/10.1038/s41401-022-00948-w.

[50] Bazzazi H, Zhang Y, Jafarnejad M, Isenberg JS, Annex BH, Popel AS. Computer simulation of TSP1 inhibition of VEGF-Akt-eNOS: An angiogenesis triple threat. Front Physiol 2018; 9: 644. https://doi.org/10.3389/fphys.2018.00644.

[51] Singla B, Aithbathula RV, Pervaiz N, Kathuria I, Swanson M, Ekuban FA, et al. CD47 activation by Thrombospondin-1 in lymphatic endothelial cells suppresses Lymphangiogenesis and promotes atherosclerosis. Arterioscler Thromb Vasc Biol 2023; 43: 1234-50. https://doi.org/10.1161/atvbaha.122.318904.

[52] Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012; 13: 358-69. https://doi.org/10.1038/nrg3198.

[53] McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of microRNA targeting efficacy. Science 2019; 366: eaav1741. https://doi.org/10.1126/science.aav1741.

[54] Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res 2020; 48: D127-d131. https://doi.org/10.1093/nar/gkz757.

[55] Zhou Y, Ng DYE, Richards AM, Wang P. microRNA-221 inhibits latent TGF-β1 activation through targeting Thrombospondin-1 to attenuate kidney failure-induced cardiac fibrosis. Mol Ther Nucleic Acids 2020; 22: 803-14. https://doi.org/10.1016/j.omtn.2020.09.041.

[56] Farberov S, Meidan R. Fibroblast growth factor-2 and transforming growth factor-beta1 oppositely regulate miR-221 that targets thrombospondin-1 in bovine luteal endothelial cells. Biol Reprod 2018; 98: 366-75. https://doi.org/10.1093/biolre/iox167.

[57] Gao B, Wang X, Wang M, You K, Ahmed Suleiman GS, Ren XK, et al. Superlow dosage of intrinsically bioactive zinc metal-organic frameworks to modulate endothelial cell morphogenesis and significantly rescue ischemic disease. ACS Nano 2022; 16: 1395-408. https://doi.org/10.1021/acsnano.1c09427.

[58] Elbarbary RA, Maquat LE. Evaluating the susceptibility of AGO2-loaded microRNAs to degradation by nucleases in vitro. Methods 2019; 152: 18-22. https://doi.org/10.1016/j.ymeth.2018.05.010.

[59] Matusek T, Wendler F, Polès S, Pizette S, D’Angelo G, Fürthauer M, et al. The ESCRT machinery regulates the secretion and long-range activity of hedgehog. Nature 2014; 516: 99-103. https://doi.org/10.1038/nature13847.

[60] Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 2015; 527: 100-4. https://doi.org/10.1038/nature15376.

[61] Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature 2015; 527: 329-35. https://doi.org/10.1038/nature15756.

[62] Zhao X, Luo J, Huang Y, Mu L, Chen J, Liang Z, et al. Injectable Antiswelling and high-strength bioactive hydrogels with a wet adhesion and rapid gelling process to promote Sutureless wound closure and scar-free repair of infectious wounds. ACS Nano 2023; 17: 22015-34. https://doi.org/10.1021/acsnano.3c08625.

[63] Fairbanks BD, Schwartz MP, Bowman CN, Anseth KS. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 2009; 30: 6702-7. https://doi.org/10.1016/j.biomaterials.2009.08.055.

[64] Marín-Ramos NI, Thein TZ, Ghaghada KB, Chen TC, Giannotta SL, Hofman FM. miR-18a inhibits BMP4 and HIF-1α normalizing brain arteriovenous malformations. Circ Res 2020; 127: e210-31. https://doi.org/10.1161/circresaha.119.316317.

[65] Abbas CA, Sibirny AA. Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev 2011; 75: 321-60. https://doi.org/10.1128/mmbr.00030-10.

[66] Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A. CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resist Updat 2023; 68: 100948. https://doi.org/10.1016/j.drup.2023.100948.

[67] Abdel-Wahab O, Levine RL. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood 2013; 121: 3563-72. https://doi.org/10.1182/blood-2013-01-451781.

[68] Cavallaro S, Pevere F, Stridfeldt F, Görgens A, Paba C, Sahu SS, et al. Multiparametric profiling of single nanoscale extracellular vesicles by combined atomic force and fluorescence microscopy: correlation and heterogeneity in their molecular and biophysical features. Small 2021; 17: e2008155. https://doi.org/10.1002/smll.202008155.

[69] Ghanam J, Chetty VK, Zhu X, Liu X, Gelléri M, Barthel L, et al. Single molecule localization microscopy for studying small extracellular vesicles. Small 2023; 19: e2205030. https://doi.org/10.1002/smll.202205030.

[70] Möller A, Lobb RJ. The evolving translational potential of small extracellular vesicles in cancer. Nat Rev Cancer 2020; 20: 697-709. https://doi.org/10.1038/s41568-020-00299-w.

[71] Jeong K, Yu YJ, You JY, Rhee WJ, Kim JA. Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model. Lab Chip 2020; 20: 548-57. https://doi.org/10.1039/c9lc00958b.

[72] Klotz BJ, Gawlitta D, Rosenberg A, Malda J, Melchels FPW. Gelatin-Methacryloyl hydrogels: towards biofabrication-based tissue repair. Trends Biotechnol 2016; 34: 394-407. https://doi.org/10.1016/j.tibtech.2016.01.002.

[73] Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials 2015; 73: 254-71. https://doi.org/10.1016/j.biomaterials.2015.08.045.

[74] Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011; 23: H41-56. https://doi.org/10.1002/adma.201003963.

[75] Maleki A, He J, Bochani S, Nosrati V, Shahbazi MA, Guo B. Multifunctional photoactive hydrogels for wound healing acceleration. ACS Nano 2021; 15: 18895-930. https://doi.org/10.1021/acsnano.1c08334.

[76] Zhong R, Talebian S, Mendes BB, Wallace G, Langer R, Conde J, et al. Hydrogels for RNA delivery. Nat Mater 2023; 22: 818-31. https://doi.org/10.1038/s41563-023-01472-w.

[77] Hu H, Dong L, Bu Z, Shen Y, Luo J, Zhang H, et al. miR-23a-3p-abundant small extracellular vesicles released from Gelma/nanoclay hydrogel for cartilage regeneration. J Extracell Vesicles 2020; 9: 1778883. https://doi.org/10.1080/20013078.2020.1778883.

[78] Zhang S, Xie Y, Yan F, Zhang Y, Yang Z, Chen Z, et al. Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis. Autophagy 2022; 18: 2229-45. https://doi.org/10.1080/15548627.2021.2016231.

[79] Xu C, Wu P, Yang K, Mu C, Li B, Li X, et al. Multifunctional biodegradable conductive hydrogel regulating microenvironment for stem cell therapy enhances the nerve tissue repair. Small 2024; 20:e2309793. https://doi.org/10.1002/smll.202309793.

[80] Zhou Z, Deng T, Tao M, Lin L, Sun L, Song X, et al. Snail-inspired AFG/GelMA hydrogel accelerates diabetic wound healing via inflammatory cytokines suppression and macrophage polarization. Biomaterials 2023; 299: 122141. https://doi.org/10.1016/j.biomaterials.2023.122141.

[81] Song W, Guo Y, Liu W, Yao Y, Zhang X, Cai Z, et al. Circadian rhythm-regulated ADSC-derived sEVs and a triphasic microneedle delivery system to enhance tendon-to-bone healing. Adv Mater 2024; 36: e2408255. https://doi.org/10.1002/adma.202408255.

[82] Bergqvist M, Lässer C, Crescitelli R, Park KS, Lötvall J. A non-centrifugation method to concentrate and purify extracellular vesicles using superabsorbent polymer followed by size exclusion chromatography. J Extracell Vesicles 2025; 14: e70037. https://doi.org/10.1002/jev2.70037.

[83] He J, Sun Y, Gao Q, He C, Yao K, Wang T, et al. Gelatin Methacryloyl hydrogel, from standardization, performance, to biomedical application. Adv Healthc Mater 2023; 12:e2300395. https://doi.org/10.1002/adhm.202300395.

[84] Xie X, Song Q, Dai C, Cui S, Tang R, Li S, et al. Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial. Gen Psychiatr 2023; 36: e101143. https://doi.org/10.1136/gpsych-2023-101143.

[85] Rahnama M, Heidari M, Poursalehi Z, Golchin A. Global trends of exosomes application in clinical trials: a scoping review. Stem Cell Rev Rep 2024; 20: 2165-93. https://doi.org/10.1007/s12015-024-10791-7.

[86] Capella-Monsonís H, Crum RJ, Hussey GS, Badylak SF. Advances, challenges, and future directions in the clinical translation of ECM biomaterials for regenerative medicine applications. Adv Drug Deliv Rev 2024; 211: 115347. https://doi.org/10.1016/j.addr.2024.115347.